Reza Dana, M.D., M.P.H., M.Sc.

Profile

Reza Dana, M.D., M.P.H., M.Sc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Claes Dohlman Professor of Ophthalmology, Harvard Medical School

Vice Chairman, Harvard Department of Ophthalmology, and Associate Chief of Ophthalmology for Academic Programs, Massachusetts Eye and Ear Infirmary

Senior Scientist & W Clement Stone Scholar, Schepens Eye Research Institute

Director, Cornea & Refractive Surgery, Massachusetts Eye and Ear Infirmary, and Director, Harvard Medical School Department of Ophthalmology Cornea Center of Excellence


In addition to his role as Senior Scientist at the Schepens Eye Research Institute, Dr. Reza Dana holds the Claes H. Dohlman Chair in Ophthalmology at Harvard Medical School. He is Director of the Harvard Medical School Cornea Center of Excellent as well as the Cornea & Refractive Surgery Service at the Mass. Eye & Ear, and serves as the Vice Chairman of the Harvard Department of Ophthalmology and Associate Chief of Ophthalmology for Academic Programs at the Massachusetts Eye and Ear Infirmary.

After graduating Summa Cum Laude from St. Paul’s School in New Hampshire, he completed his bachelor’s (Phi Beta Kappa), graduate, and medical education at Johns Hopkins University. He performed his residency in Ophthalmology at the Illinois Eye and Ear Infirmary in Chicago, followed by a clinical fellowship in Cornea and External Diseases at the Wills Eye Hospital in Philadelphia. Dr. Dana then completed additional fellowship training in Immunology and Uveitis at the Massachusetts Eye and Ear Infirmary, and in Ocular and Transplantation Immunology at the Schepens Eye Research Institute. Dr. Dana also holds a Master of Science degree in Management from Harvard University.

Dr. Dana has been a member of the full-time Harvard faculty since 1995. As a clinician-scientist, he has a particular interest in the molecular and cellular mechanisms of inflammation as they pertain to the ocular surface and anterior segment pathologies, including dry eye, allergy, wound healing responses, and transplant rejection.

Dr. Dana has authored over 300 publications—including nearly 200 peer-reviewed articles, in addition to over 100 reviews, book chapters, and communications. He has delivered more than 120 invited and named lectures worldwide, and has been recipient of multiple awards, including the Research to Prevent Blindness William and Mary Greve Special Scholar Award, RPB Physician-Scientist Merit Award, RPB Lew Wasserman Merit Award and RPB Senior Investigator Award, the Achievement Award of the American Academy of Ophthalmology, the Cogan Award of the Association for Research in Vision and Ophthalmology, the LSU Chancellor’s Award in Neuroscience and Ophthalmology, and the Alcon Research Institute Award. Dr. Dana is a Gold Fellow of ARVO.

Dr. Dana has served as editor of the Eye and Systemic Disease volume of The Principles and Practice of Ophthalmology and as member of the faculty of the American Academy of Ophthalmology’s Basic Clinical and Science Course where he was responsible for content in Cornea and External Diseases book, and as Senior Editor of the Encyclopedia of the Eye. Dr. Dana is additionally Associate Editor of IOVS, and is on the editorial board of the journals Cornea and The Ocular Surface among others, and is an Associate Examiner of the American Board of Ophthalmology.

In addition to his fundamental contributions to our understanding of corneal pathobiology in the areas of transplant rejection, angiogenesis and lymphangiogenesis, and dry eye disease, emanating from his laboratory research, Dr. Dana has developed one of the leading translational programs in ophthalmology. He created the Cornea Research Department at the Mass Eye and Ear in 2007, currently staffed by 7 full-time staff, where 50+ (as of last count) prospective investigator-initiated studies are being performed by the Cornea Center faculty. Studies have focused on novel strategies to manage high-risk corneal and stem cell transplants, pathological corneal angiogenesis, dry eye, and in vivo corneal immuno- and neuro-imaging. These studies have been facilitated by 7 successful FDA Investigational New Drug (IND) approvals received since 2008.

Education

1981, Diploma Summa Cum Laude, Saint Paul’s School, Concord NH
1985, Bachelor of Arts (BA) Phi Beta Kappa, Johns Hopkins University
1989, Master of Public Health (MPH), Johns Hopkins University
1989, Doctor of Medicine (MD), Johns Hopkins University
2005, Master of Science (MSc) in Health Care Management, Harvard University

Contact

Telephone:

Basic Res Admin: 617-912-7401
Clinical Res Admin: 617-573-4439
Clinical/Surgical Care: 617-573-4331

Fax Numbers:

Research Office: 617-912-0117
Clinical Office: 617-573-4300

Email:

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.